NCT06648057 2026-03-18
Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
CHA University
Recruiting
CHA University
CHA University
CHA University
The Institute of Molecular and Translational Medicine, Czech Republic
Boston Children's Hospital